Illness perceptions predict distress in patients with chronic kidney disease.

Chronic kidney disease Depression and anxiety Distress Illness perceptions Treatment perceptions

Journal

BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676

Informations de publication

Date de publication:
07 May 2021
Historique:
received: 02 02 2020
accepted: 22 04 2021
entrez: 8 5 2021
pubmed: 9 5 2021
medline: 12 5 2021
Statut: epublish

Résumé

Patients diagnosed with chronic kidney disease (CKD) report increased distress associated with their clinical diagnosis. Distress in patients with predialysis CKD, has been linked to several adverse events; including increased risk of hospitalisation, early dialysis initiation and even death, suggesting that distress is a matter of great concern during routine care in predialysis CKD. The present study aimed to assess the nature of illness perceptions and the level of distress in a CKD cohort diagnosed with different stages of kidney disease. It also aimed to explore the correlates of distress and to create a model for distress and its associated predictors making use of hierarchical regression analysis. A sample of 200 patients diagnosed with Chronic Kidney Disease were recruited for this study from the nephrology outpatient clinics of Mater Dei Hospital, Malta. The participants were assessed for their; illness perceptions, treatment beliefs, level of depression and anxiety, coping style, as well as treatment adherence. Routine clinical information was also collected for participants, including a co-morbidity score. A percentage of 33.5% of the participants reported moderate distress, whilst 9.5% reported severe distress. Stronger illness identity, a perception of timeline as being increasingly chronic or cyclical in nature, greater consequences and higher emotional representations were associated with more advanced stages of CKD. In contrast, lower personal and treatment control and poorer illness coherence were associated with more advanced stages of CKD. Results from the hierarchical regression analysis showed that illness perceptions contributed significantly to distress over and above the clinical kidney factors. Being female, having low haemoglobin and specific illness perceptions including; perceptions of greater symptomatology, longer timeline, low personal control and strong emotional representations, as well as resorting to maladaptive coping, were all significantly associated with distress symptoms. Nevertheless, illness perceptions accounted for the greatest variance in distress thus indicating that the contribution of illness perceptions is greater than that made by the other known covariates. Illness perceptions hold a principal role in explaining distress in CKD, relative to other traditional covariates. For this reason, illness perceptions should be addressed as a primary modifiable component in the development of distress in CKD.

Sections du résumé

BACKGROUND BACKGROUND
Patients diagnosed with chronic kidney disease (CKD) report increased distress associated with their clinical diagnosis. Distress in patients with predialysis CKD, has been linked to several adverse events; including increased risk of hospitalisation, early dialysis initiation and even death, suggesting that distress is a matter of great concern during routine care in predialysis CKD.
AIMS OBJECTIVE
The present study aimed to assess the nature of illness perceptions and the level of distress in a CKD cohort diagnosed with different stages of kidney disease. It also aimed to explore the correlates of distress and to create a model for distress and its associated predictors making use of hierarchical regression analysis.
METHODS METHODS
A sample of 200 patients diagnosed with Chronic Kidney Disease were recruited for this study from the nephrology outpatient clinics of Mater Dei Hospital, Malta. The participants were assessed for their; illness perceptions, treatment beliefs, level of depression and anxiety, coping style, as well as treatment adherence. Routine clinical information was also collected for participants, including a co-morbidity score.
RESULTS RESULTS
A percentage of 33.5% of the participants reported moderate distress, whilst 9.5% reported severe distress. Stronger illness identity, a perception of timeline as being increasingly chronic or cyclical in nature, greater consequences and higher emotional representations were associated with more advanced stages of CKD. In contrast, lower personal and treatment control and poorer illness coherence were associated with more advanced stages of CKD. Results from the hierarchical regression analysis showed that illness perceptions contributed significantly to distress over and above the clinical kidney factors. Being female, having low haemoglobin and specific illness perceptions including; perceptions of greater symptomatology, longer timeline, low personal control and strong emotional representations, as well as resorting to maladaptive coping, were all significantly associated with distress symptoms. Nevertheless, illness perceptions accounted for the greatest variance in distress thus indicating that the contribution of illness perceptions is greater than that made by the other known covariates.
CONCLUSION CONCLUSIONS
Illness perceptions hold a principal role in explaining distress in CKD, relative to other traditional covariates. For this reason, illness perceptions should be addressed as a primary modifiable component in the development of distress in CKD.

Identifiants

pubmed: 33962685
doi: 10.1186/s40359-021-00572-z
pii: 10.1186/s40359-021-00572-z
pmc: PMC8105921
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

75

Subventions

Organisme : Force 5 Company Limited
ID : 05/2013

Références

J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Int J Behav Med. 1997;4(1):92-100
pubmed: 16250744
Chest. 2006 Jul;130(1 Suppl):65S-72S
pubmed: 16840369
Psychol Health Med. 2012;17(5):578-88
pubmed: 22304230
J Pers Soc Psychol. 1993 Aug;65(2):375-90
pubmed: 8366426
BMC Nephrol. 2013 Apr 04;14:78
pubmed: 23557031
BMC Nephrol. 2012 Oct 08;13:133
pubmed: 23043743
Semin Dial. 2012 Jul;25(4):428-38
pubmed: 22809005
Gen Hosp Psychiatry. 2018 Jan - Feb;50:15-19
pubmed: 28985589
Am J Med Sci. 2014 Oct;348(4):271-6
pubmed: 24751421
Br J Health Psychol. 2013 May;18(2):244-62
pubmed: 23126527
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Am J Kidney Dis. 1998 Oct;32(4):557-66
pubmed: 9774115
BMJ Open. 2019 May 15;9(5):e027982
pubmed: 31097489
Psychosom Med. 2016 Jul-Aug;78(6):716-27
pubmed: 27187854
BMC Nephrol. 2020 Dec 10;21(1):537
pubmed: 33302894
Am J Kidney Dis. 2009 Oct;54(4):741-52
pubmed: 19592143
Am J Kidney Dis. 2020 Jan;75(1 Suppl 1):A6-A7
pubmed: 31704083
J Psychosom Res. 2010 Feb;68(2):203-12
pubmed: 20105704
Br J Clin Pharmacol. 2020 Jul;86(7):1281-1288
pubmed: 31823381
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
Am J Nephrol. 2011;33(4):358-63
pubmed: 21430374
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Am J Kidney Dis. 2008 Apr;51(4):651-62
pubmed: 18371541
Clin J Am Soc Nephrol. 2007 Sep;2(5):919-25
pubmed: 17702733
Clin Med (Lond). 2006 Nov-Dec;6(6):536-9
pubmed: 17228551
J Psychosom Res. 2002 Oct;53(4):951-6
pubmed: 12377308
Am J Kidney Dis. 2009 Sep;54(3):424-32
pubmed: 19493599
J Am Soc Nephrol. 2007 Dec;18(12):3042-55
pubmed: 18003775
Psychol Bull. 2017 Nov;143(11):1117-1154
pubmed: 28805401
Am J Kidney Dis. 1990 Jan;15(1):31-9
pubmed: 2294731
Clin Biochem. 2013 Oct;46(15):1423-9
pubmed: 23747959
Am J Kidney Dis. 2014 Apr;63(4):623-35
pubmed: 24183836
J Ren Care. 2018 May 27;:
pubmed: 29806175
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
Kidney Int. 1994 Apr;45(4):1163-9
pubmed: 8007587
Kidney Int. 2000 Apr;57(4):1720-6
pubmed: 10760108

Auteurs

Priscilla Muscat (P)

Health Psychology Section, Psychology Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5th floor Bermondsey Wing, Guy's Campus, London, SE1 9RT, UK. priscilla.muscat@kcl.ac.uk.

John Weinman (J)

Institute of Pharmaceutical Science, Pharmaceutical Sciences Clinical Academic Group, King's College London, 5th floor, Franklin -Wilkins Building, 150 Stamford Street, London, SE19NH, UK.

Emanuel Farrugia (E)

Nephrology Department, Mater Dei Hospital, Msida, Malta.

Roberta Callus (R)

Nephrology Department, Mater Dei Hospital, Msida, Malta.

Joseph Chilcot (J)

Health Psychology Section, Psychology Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5th floor Bermondsey Wing, Guy's Campus, London, SE1 9RT, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH